Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
ObjectivesTo evaluate the impact of smoking history on the clinical benefit of immunotherapy in patients with non-small cell lung cancer (NSCLC).MethodsTwenty-three randomized clinical trials and seven real-world studies were included in this meta-analysis. Hazard ratios (HRs) and 95% confidence int...
Main Authors: | Wenhua Zhao, Wei Jiang, Huilin Wang, Jianbo He, Cuiyun Su, Qitao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.703143/full |
Similar Items
-
Prognostic value of pretreatment smoking status for small cell lung cancer: A meta‐analysis
by: Liling Huang, et al.
Published: (2020-11-01) -
NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
by: Song P, et al.
Published: (2020-07-01) -
Immunotherapy for small-cell lung cancer
by: A. Ye. Kuzminov, et al.
Published: (2019-06-01) -
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study
by: Alessio Cortellini, et al.
Published: (2021-03-01) -
Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)